Acute hepatitis B with delta-agent
ICD-10 B16 is a billable code used to indicate a diagnosis of acute hepatitis b with delta-agent.
Acute hepatitis B with delta-agent is a viral infection caused by the hepatitis B virus (HBV) in conjunction with the hepatitis D virus (HDV). This condition is characterized by the rapid onset of liver inflammation, which can lead to significant liver damage if not managed appropriately. The delta agent, or hepatitis D virus, requires the presence of HBV to replicate, making co-infection particularly severe. Transmission occurs primarily through exposure to infectious body fluids, including blood, semen, and vaginal secretions. High-risk populations include intravenous drug users, individuals with multiple sexual partners, and those with occupational exposure to blood. Symptoms may include jaundice, fatigue, abdominal pain, and elevated liver enzymes. Chronic management focuses on monitoring liver function, potential antiviral therapy, and lifestyle modifications to prevent further liver damage. Complications can include acute liver failure, chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Early diagnosis and intervention are crucial to mitigate these risks and improve patient outcomes.
Detailed patient history, risk factors, laboratory results, and treatment plans.
Diagnosis of acute hepatitis in high-risk populations, management of co-infections.
Ensure all laboratory tests are documented to support the diagnosis of acute hepatitis B with delta-agent.
Comprehensive liver function tests, imaging studies, and treatment response documentation.
Management of liver complications, monitoring for cirrhosis or hepatocellular carcinoma.
Document any liver biopsies or imaging studies performed to assess liver damage.
Used to confirm diagnosis of acute hepatitis B.
Document the reason for testing and results.
Infectious disease specialists should ensure comprehensive testing for co-infections.
The delta agent, or hepatitis D virus, complicates hepatitis B infections and can lead to more severe liver disease. It requires the presence of hepatitis B to replicate, making co-infection particularly dangerous.
